D419br00008- A Prospective, Non-Interventional Study To Assess The Prevalence Of Pd-L1 Expression In The First-Line Setting Of Locally Advanced/Unresectable Or Metastatic Urothelial Carcinoma
Posted Date: Feb 5, 2020
- Investigator: Shuchi Gulati
- Specialties: Cancer, Oncology
- Type of Study: Observational/Survey
The primary goal of this study is to assess the prevalence of pre-treatment tumor tissue PD-L1 high expression in the 1L setting in advanced UC patients (locally advanced/unresectable or metastatic) using the Ventana SP263 assay.
Criteria:
Must Have Urothelial Carcinoma, Be At Least 18 Years Of Age, No Prior Systemic Therapy For Uc, No History Of Non-Urothelial Malignancy Within 2 Years,
Keywords:
Urothelial Cancer, Gu
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com